Immunosuppressive and antitumor activity of periodate oxidation product of beta-D-ribosyl-6-methylthiopurine.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002247:Carbon Isotopes; D005260:Female; D005998:Glycine / Q000378:metabolism; D006386:Hemagglutination Tests; D007093:Imidazoles / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D010084:Oxidation-Reduction; D010504:Periodic Acid / Q000494:pharmacology*; D014176:Protein Biosynthesis; D011687:Purines / Q000096:biosynthesis / Q000378:metabolism; D051381:Rats; D016038:Skin Transplantation; D013154:Spleen / Q000378:metabolism; D014181:Transplantation Immunology / Q000187:drug effects; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D007093:Imidazoles; D007166:Immunosuppressive Agents; D011687:Purines; D010504:Periodic Acid; D000225:Adenine; D005998:Glycine